Is LCI a buy? - Seeking Alpha

Quote & Headlines Market Currents StockTalk

Today 5d 1m 3m 1y 5y 10y

52wk high:

52wk low:

EPS:

PE:

Div Rate:

Yield:

Market Cap:

Volume:

250 people get LCI articles and Market Currents by email alert.

Get email alerts on LCI »

HEADLINES:

Lannett Management Discusses Q3 2013 Results - Earnings Call Transcript
Wed, May 8
Lannett Reports Record Fiscal 2013 Third Quarter Financial Results

Business Wire (May 8, 2013)
Lannett Announces Preliminary Fiscal 2013 Third Quarter Net Sales of $39 Million, Earnings Per Share between $0.12 and $0.14

Business Wire (Apr 30, 2013)
Lannett to Present at Needham’s 12th Annual Healthcare Conference

Business Wire (Apr 23, 2013)
Lannett to Present at 25th Annual Roth Conference March 18

Business Wire (Mar 12, 2013)
Lannett Management Discusses Q2 2013 Results - Earnings Call Transcript
Thu, Feb 7
Lannett Reports Strong Financial Results for Fiscal 2013 Second Quarter

Business Wire (Feb 7, 2013)
Lannett Announces Preliminary Financial Results for Fiscal 2013 Second Quarter

Business Wire (Jan 31, 2013)
Lannett’s Universal Shelf Registration Statement Declared Effective

Business Wire (Dec 7, 2012)
Lannett to Present at Oppenheimer 23rd Annual Healthcare Conference on December 12th

Business Wire (Dec 5, 2012)
This $4.50 Drug Stock Has Good Growth Prospects Ahead Of It
Bret Jensen • Mon, Nov 12, 2012 • 2 Comments
Lannett Reports Strong Fiscal 2013 First Quarter Financial Results

Business Wire (Nov 8, 2012)
Lannett Donates to Red Cross to Support Hurricane Sandy Relief Efforts

Business Wire (Nov 5, 2012)
Lannett to Report Fiscal 2013 First Quarter Financial Results and Host Conference Call on Thursday, November 8

Business Wire (Nov 2, 2012)
Lannett Returns To Profitability, Reports Strong Sales Growth
Mike Havrilla • Fri, Sep 14, 2012
Lannett Receives FDA Approval for Butalbital, Acetaminophen and Caffeine Tablets USP, 50mg/325mg/40mg

Business Wire (Sep 14, 2012)
Lannett to Present at UBS Global Life Sciences Conference

Business Wire (Sep 13, 2012)
Lannett Reports Fiscal 2012 Fourth-Quarter, Full-Year Financial Results

Business Wire (Sep 6, 2012)
Lannett to Report Fiscal 2012 Fourth-Quarter, Full-Year Financial Results and Host Conference Call on Thursday, September 6

Business Wire (Aug 29, 2012)
3 Healthcare Stocks With Strong Buy Analyst Ratings And Minimal Debt
ZetaKap • Thu, Aug 23, 2012

To learn more about Seeking Alpha Pro, click here.

This $4.50 Drug Stock Has Good Growth Prospects Ahead Of It
Bret Jensen • Mon, Nov 12, 2012 • 2 Comments
Lannett Returns To Profitability, Reports Strong Sales Growth
Mike Havrilla • Fri, Sep 14, 2012
Lannett: Small-Cap Growth Pharma Trading At Value Prices
Mike Havrilla • Thu, Jun 21, 2012 • 4 Comments
Lannett Drops After FDA Approval With More Decisions Pending
Mike Havrilla • Fri, Jul 1, 2011 • 1 Comment
Lannett Awaits 3 Expected FDA Decisions
Mike Havrilla • Wed, May 4, 2011
Commodities, Roll Yield and Contango
Hard Assets Investor • Mon, Mar 31, 2008

3 Healthcare Stocks With Strong Buy Analyst Ratings And Minimal Debt
ZetaKap • Thu, Aug 23, 2012
8 Healthcare Stocks With Unusually High P/E Ratios
Kinetic Investments • Thu, Dec 29, 2011 • 3 Comments
18 High-Growth Smart Money Picks Trading Under $5
Kapitall • Thu, Sep 8, 2011 • 2 Comments
Busy Week for FDA Leads to Volatile Action in 5 Pharma Stocks
Alex Shadunsky • Mon, Jun 27, 2011 • 2 Comments
4 Pharma Stocks That Should See a Surge in Interest Next Week
Alex Shadunsky • Thu, Jun 16, 2011 • 8 Comments
Cardium Therapeutics, Lannett: Dealing With Debilitating Biotech Situations
Spencer Knight • Mon, Apr 11, 2011 • 5 Comments
How to Maneuver the Biotech Sector
Spencer Knight • Tue, Mar 29, 2011 • 2 Comments
Life Sciences Companies Raise Record Amounts of Capital
The Burrill Report • Fri, Dec 31, 2010
BioSante Attracts Institutional Investors Ahead of Key FDA Catalysts in 2011
TheMarketFinancial • Tue, Dec 28, 2010 • 3 Comments
Endo Pharma Expands Into Generic Drugs With Recent Acquisitions
Mike Havrilla • Tue, Sep 28, 2010
10 Year-End Stock Trades on FDA Binary Events
Mike Havrilla • Mon, Sep 27, 2010
2 Year-End FDA Run-Up Stock Plays
Mike Havrilla • Tue, Sep 14, 2010 • 1 Comment
Why You Should Diversify With U.S. Stocks
The GeoTeam • Thu, May 13, 2010 • 2 Comments
Big Lineup of Healthcare Stocks Crack the Russell 3000 Index
M. E. Garza • Wed, Jul 1, 2009
20 Bullish Stocks, 2 Detailed Trades
Option Maestro • Tue, Jun 30, 2009 • 1 Comment
Caraco Pharma Poised for a Turnaround
Mike Havrilla • Sat, May 30, 2009 • 10 Comments
Biotech Going Generic Like Big Pharma?
Mike Havrilla • Mon, Mar 2, 2009 • 2 Comments
A 130/30 Generic Pharma Trading Strategy
Mike Havrilla • Tue, Feb 24, 2009 • 1 Comment

Lannett Reports Record Fiscal 2013 Third Quarter Financial Results

Business Wire (May 8, 2013)
Lannett Announces Preliminary Fiscal 2013 Third Quarter Net Sales of $39 Million, Earnings Per Share between $0.12 and $0.14

Business Wire (Apr 30, 2013)
Lannett to Present at Needham’s 12th Annual Healthcare Conference

Business Wire (Apr 23, 2013)
Lannett to Present at 25th Annual Roth Conference March 18

Business Wire (Mar 12, 2013)
Lannett Reports Strong Financial Results for Fiscal 2013 Second Quarter

Business Wire (Feb 7, 2013)
Lannett Announces Preliminary Financial Results for Fiscal 2013 Second Quarter

Business Wire (Jan 31, 2013)
Lannett’s Universal Shelf Registration Statement Declared Effective

Business Wire (Dec 7, 2012)
Lannett to Present at Oppenheimer 23rd Annual Healthcare Conference on December 12th

Business Wire (Dec 5, 2012)
Lannett Reports Strong Fiscal 2013 First Quarter Financial Results

Business Wire (Nov 8, 2012)
Lannett Donates to Red Cross to Support Hurricane Sandy Relief Efforts

Business Wire (Nov 5, 2012)
Lannett to Report Fiscal 2013 First Quarter Financial Results and Host Conference Call on Thursday, November 8

Business Wire (Nov 2, 2012)
Lannett Receives FDA Approval for Butalbital, Acetaminophen and Caffeine Tablets USP, 50mg/325mg/40mg

Business Wire (Sep 14, 2012)
Lannett to Present at UBS Global Life Sciences Conference

Business Wire (Sep 13, 2012)
Lannett Reports Fiscal 2012 Fourth-Quarter, Full-Year Financial Results

Business Wire (Sep 6, 2012)
Stocks to Watch: Stocks to watch Thursday: Supervalu, OCZ, VeriFone

at MarketWatch.com (Sep 6, 2012)
Lannett to Report Fiscal 2012 Fourth-Quarter, Full-Year Financial Results and Host Conference Call on Thursday, September 6

Business Wire (Aug 29, 2012)
Lannett Company Names Jeffrey Farber as Chairman

Business Wire (Jul 16, 2012)
Lannett Company Adds Paul Taveira to Board of Directors

Business Wire (May 11, 2012)
Lannett Reports Fiscal 2012 Third Quarter Financial Results

Business Wire (May 8, 2012)
Lannett to Report Fiscal 2012 Third-Quarter Financial Results and Host Conference Call on Tuesday, May 8

Business Wire (May 2, 2012)

LCI vs. ETF Alternatives

Company Description

Currently, there's no company description for LCI.

Sector: Healthcare

Industry: Drug Manufacturers - Other

Country: United States

All
| Earnings
| Dividends
| M&A
| On the move

Thursday, May 23, 12:11 PM Shares of small-cap, generic pharmaceutical maker Lannett Company (LCI +5%) get a boost today after being initiated at Needham with a Buy rating and a price target of $15. The firm calls FY13 a transition year for LCI as its operations are positioned for strong future growth, with potentially significant upside coming from additional generic approvals/product launches, and progress around key product filings. Technical note: The stock is currently in the process of breaking out of its 52-week range of $3.72 - $12.57. Comment! [Healthcare, Quick Ideas, On the Move]
Wednesday, May 8, 4:49 PM Lannett (LCI): FQ3 EPS of $0.14 beats by $0.01. Revenue of $39M (+27% Y/Y) beats by $3.86M. (PR) Comment! [Earnings, Breaking News, Healthcare]
Friday, April 19, 5:32 PM After-hours top gainers, as of 5:15 p.m.: AMSC +4%. PCYG +3%. UVXY +3%. FIG +3%. ABX +3%.
After-hours top losers: LCI -6%. FMX -6%. STI -4%. FNFG -3%. WSB -3%. Comment! [On the Move]
Friday, February 15, 5:46 PM After-hours top gainers, as of 5:15 p.m.: PSUN +6%. NSM +5%. MGM +4%. NOG +4%. HK +4%.
After-hours top losers: SKH -5%. EPB -5%. WOOF -4%. LCI -4%. PRSS -3%. Comment! [On the Move]
Thursday, February 7, 6:10 PM Lannett (LCI): FQ2 EPS of $0.10 beats by $0.05. Revenue of $36.6M (+32% Y/Y) beats by $3M. Shares +2.2% premarket. (PR) Comment! [Earnings, Breaking News, Healthcare, On the Move]
Thursday, September 6, 2012, 4:29 PM Lannett (LCI): FQ4 EPS of $0.05 beats by $0.02. Revenue of $35.7M (+40% Y/Y) beats by $2.7M. (PR) Comment! [Earnings, Healthcare]
Monday, January 30, 2012, 8:24 AM Shares of Lannett Company (LCI) gain 3.6% premarket after the company lands FDA approval for its Hydrochlorothiazide capsules used to treat high blood pressure. Comment! [On the Move, Healthcare]
Tuesday, December 14, 2010, 9:00 AM Premarket gainers: GXDX +17%. AMGN +4%. BP +4%.
Losers: LCI -13%. BBY -13%. LPH -12%. ICO -11%. LXRX -10%. YMI -8%. AHT -6%. OXPS -5%. VECO -5%. REE -5%. WPZ -4%. Comment!

ZetaKap
3 Healthcare Stocks With Strong Buy Analyst Ratings And Minimal Debt http://bit.ly/Pe3Lui $CO $LCI $OGXI @ZetaKap
8/23/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

amymaclaren
LCI
11/11/10
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

ari.l
Mela, Astm, LCI, Orex
10/29/10
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Capitalist Bull
SWHC and LCI reported great #'s after hours...
9/9/09
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

LATEST REPLIES

LCI Lannett Company, Inc

LCI

Lannett Company, Inc